S
ISSUER//CIK 0001106838
Sonnet BioTherapeutics Holdings, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Sep 30
Headquarters
DE
Recent Filings
- 10-K9.3 MBSonnet BioTherapeutics Holdings, Inc.Dec 16, 4:45 PM ET·0001493152-25-027978
- 8-K2.1 MBSonnet BioTherapeutics Holdings, Inc.Dec 3, 8:00 AM ET·0001493152-25-025884
- 8-K247.9 KBSonnet BioTherapeutics Holdings, Inc.Dec 2, 9:25 AM ET·0001493152-25-025677
- 8-K246.5 KBSonnet BioTherapeutics Holdings, Inc.Nov 18, 9:16 AM ET·0001493152-25-024006
- 8-K217.0 KBSonnet BioTherapeutics Holdings, Inc.Sep 29, 4:05 PM ET·0001493152-25-015994
- 10-Q5.2 MBSonnet BioTherapeutics Holdings, Inc.Aug 13, 4:06 PM ET·0001641172-25-023468
- 8-K279.0 KBSonnet BioTherapeutics Holdings, Inc.Aug 1, 4:58 PM ET·0001641172-25-021927
- 8-K204.0 KBSonnet BioTherapeutics Holdings, Inc.Jul 25, 4:05 PM ET·0001641172-25-021007
- 8-K202.3 KBSonnet BioTherapeutics Holdings, Inc.Jul 18, 4:30 PM ET·0001641172-25-020237
- 8-K3.2 MBSonnet BioTherapeutics Holdings, Inc.Jul 14, 6:30 AM ET·0001641172-25-018877
Insiders
10- ADAMS RICHARDPresident, ARB *
- Bhatt NaileshDirector
- Carroll J MichaelDirector
- Cini John K.Chief Scientific Officer
- Cross John Harry IIIChief Financial Officer
- Dexter SusanChief Technical Officer
- Dyrness Albert D.Director
- ENGLANDER ISRAEL AMay be deemed a group member.
- Glick Frederick LPresident
- Griffith Donald J.Director, Chief Financial Officer
Tickers
No tickers on record
Addresses
business
100 OVERLOOK CENTER SUITE 102
PRINCETON, NJ, 08540
mailing
100 OVERLOOK CENTER SUITE 102
PRINCETON, NJ, 08540
Former Names
- Chanticleer Holdings, Inc.2020-03-31
- TULVINE SYSTEMS INC2005-03-31